fbpx

Medicamen Biotech Ltd

MEBI.NS

$5.44

Closing

▼-3.70%

1D

▼-8.56%

YTD

MEBI

BBG001S8LX58

Exchange

Sector

Market cap

$68.94M

Volume

15,257

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$68.94M

Analysts' Rating

-

Price Target (Mean)

0.00

Total Analysts

0

P/E

66.04

Operating Margin

8.49%

Beta

Revenue Growth

2.76%

52 week high

$7.31

52 week low

$4.12

Div. Yield

0.21%

EPS Growth

0.00

Company Profile

Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in research and development, manufacturing, marketing, and distribution of pharmaceutical products. The Company manufactures products across various therapeutic categories, including Pain Management, Cough and Cold, Cardiovascular and Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic, among others. The Company manufactures a range of products, including tablets, capsules, dry syrup, non-beta lactum, ointments, and creams. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Letrozole, Melphalan, Oxaliplatin, Pazopanib, Its Cardiology products include Nifedipine Capsules, Atorvastatin Tablets, Fenofibrate Capsules, Rosuvastatin Tablets.